Glycotest gets $1 million boost from Fosun for liver cancer tests
LONDON: Glycotest, a company developing blood tests for liver cancer, has received a $1 million follow-on investment from Fosun Industrial Co., Limited, a Chinese conglomerate. The investment is part of a $10 million deal signed in 2019, which also grants…